Biotechnology News

April 24, 2012

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ: 4573) pleased to announce the completion of a phase I clinical study of RK-023, a new compound that is being developed for the treatment of hypotrichosis of the eyelashes.

April 24, 2012

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment provider, started off fiscal 2012 with substantial gains in order intake, sales revenue and earnings. Based on the company'...

April 24, 2012

DUBAI--(BUSINESS WIRE)--World Heart Federation, World Congress of Cardiology Scientific Sessions 2012 - April 23, 2012 Seventy patient and professional organisations from 39 countries united in Dubai this week at the World Heart Federation’s...

April 24, 2012

BROOMFIELD, Colo.--(BUSINESS WIRE)--OEL Fastrac, a simple an affordable way to obtain occupational exposure limits for active pharmaceutical ingredients. Visit affygility.com for more information.

April 23, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will webcast its annual meeting of shareholders on Tuesday, May 8, 2012, at 9:00 a.m. Central Time. This call is being webcast by Thomson Reuters and can be accessed along...

April 23, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced its financial results for the first quarter of 2012. First quarter 2012 results: Revenue of $273 million, a 3% decrease compared to $283 million in the first quarter of 2011...

April 23, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq:ARRY) will report financial results for the third quarter of fiscal 2012 on Monday, April 30, 2012, and will hold a conference call on Tuesday, May 1, 2012 at 9:00 a.m. Eastern time to...

April 23, 2012

GOLDEN, Colo.--(BUSINESS WIRE)--Luca Technologies Inc., a global market leader in biogenic methane gas creation and production, today announced that it has decided not to pursue its initial public offering due to adverse market conditions. The...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that David Warshawsky, Ph.D., CEO of BioTime’s subsidiary LifeMap Sciences, Inc. will provide and update on product development at an investor meeting in New York...

April 23, 2012

NEW YORK--(BUSINESS WIRE)--Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (NASDAQ:RDEA) (ISIN: US03969P1075) concerning the proposed acquisition of...

April 23, 2012

DENVER--(BUSINESS WIRE)--Accelr8 Technology Corporation (Amex: AXK) announced today that an investment group formed by Jack Schuler, John Patience, and Larry Mehren will invest a total of up to $35 million in Accelr8’s common stock. The purpose...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that BioTime’s CEO Michael West, Ph.D. will provide and update the development of OTX-CP07 by BioTime’s subsidiary OrthoCyte Corporation at an investor meeting in...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Steven Kessler, Ph.D., Vice President of Research at BioTime’s subsidiary ReCyte Therapeutics, Inc. will provide and update on the development of reprogramming...

April 23, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. will host its first-quarter 2012 financial results conference call and webcast on Tuesday, May 1, at 10 a.m. ET.

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Joseph Wagner, Ph.D., the CEO of BioTime’s subsidiary OncoCyte Corporation and Karen B. Chapman, Ph.D., Director of Bioinformatics will provide updates on the...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) announced today that Charles S. Irving, Ph.D., the CEO of BioTime’s subsidiary Cell Cure Neurosciences, Ltd. will provide an update on the development of OpRegen® at an investor...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex:BTX) announced today that William Tew, Ph.D., BioTime’s Chief Commercial Officer will provide an update on the development of ReneviaTM (formerly known as HyStem®-Rx) at an investor...

April 23, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Landec Corporation (Nasdaq:LNDC), a company that develops and markets patented products for food, agricultural and biomedical applications, announced today that its wholly owned food subsidiary, Apio, Inc.,...

April 23, 2012

HOUSTON--(BUSINESS WIRE)--Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, closed a $3 million Series A convertible preferred stock financing.

April 23, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck today announced the launch of YourPartnerInEpilepsy.com, a new destination for the epilepsy community to learn about epilepsy, get involved and find inspiration. Among the website’s many features include...

April 23, 2012

EXTON, Pa.--(BUSINESS WIRE)--After three months on the market, share of Regeneron’s Eylea has increased to 6 percent

April 23, 2012

ATLANTA--(BUSINESS WIRE)--Capsalus Corp. announced that the necessary revenue numbers for its fourth quarter are not yet available for its Fiscal 2011 10-K annual report for the fiscal year ending Dec. 31, 2011.

April 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The rapid growth of Phase IV clinical trials has meant expanded budgets for post-marketing studies and a subsequent need to manage complex outsourcing relationships.

April 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OmniGuide, Inc., a commercial stage medical device company, today announced that it has appointed Carl Vause as its Vice President of Marketing. Mr. Vause most recently served as the Global Franchise Leader for...

April 23, 2012

SIOUX FALLS, S.D.--(BUSINESS WIRE)--The South Dakota Biotechnology Association is expanding its annual poster session for researchers by incorporating the event into its annual summit. The poster session will focus on the following areas of...

April 23, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE Amex: BTX) and its wholly owned subsidiary OrthoCyte Corporation reported today a means of manufacturing cartilage from human embryonic stem cells that is suited for industrial scale-up of a...

April 23, 2012

MILAN--(BUSINESS WIRE)--Revenues of €191.7 million, a 2.8%increase (5.1% as reported) over Q1 2011; Adjusted net profit up 10.3% to €11.2 million, 5.8% of revenues (5.6% in Q1 2011)

April 23, 2012

CAMBRIDGE, Mass. & WEST CHICAGO, Ill.--(BUSINESS WIRE)--Metabolix, Ball Horticultural Company and FPG, announced that the Mirel based biodegradable SoilWrap plant containers are now available at Home Depot and Shopko stores in Midwest and...

April 23, 2012

ABBOTT PARK, Ill. & ST. PAUL, Minn.--(BUSINESS WIRE)--Abbott (NYSE: ABT) and St. Jude Medical (NYSE: STJ) today announced Choice Alliance, a multi-year joint initiative that provides mutual U.S. customers access to a robust portfolio of...

April 23, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, today announced that its ViaValve™ Safety I.V. Catheter has been cleared by the U.S. Food and Drug Administration (FDA) and can be marketed in the...

April 23, 2012

FREMONT, Calif.--(BUSINESS WIRE)--SeptRx® completes enrollment for its “InterSEPT” CE mark trial, partners with CoRRect Medical GmbH for European distribution of its SeptRx® Intrapocket PFO Occluder (IPO)

April 23, 2012

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest and the US Army are collaborating to establish hollow fiber bioreactors as an ideal manufacturing platform for the rapid, robust and cost-effective production of anti-viral vaccines and...

April 23, 2012

BEIJING--(BUSINESS WIRE)--Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) , a technology-focused supplier of hybrid and genetically modified crop seeds in China, today announced its operating company, Beijing Origin Seed...

April 23, 2012

WASHINGTON--(BUSINESS WIRE)--Association of Clinical Research Organizations (ACRO) Testifies to FDA on Clinical Trial Modernization and Need for Chief Innovation Officer

April 23, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced the appointment of Tom Pike as chief executive officer. Dennis Gillings, CBE, who founded the company, continues as executive chairman of its Board of Directors.

April 23, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--NextBio Clinical extends the NextBio research platform from the bench to translational medicine and biomarker discovery, correlating patient clinical and genomic data to experimental ‘-Omics’.

April 23, 2012

SAVANNAH, Ga.--(BUSINESS WIRE)--Retinalyze, LLC Begins Enrolling Ophthalmology Practices

April 23, 2012

PINE BROOK, N.J. & HIROSAKI, Japan--(BUSINESS WIRE)--Ezose Sciences will use its proprietary glycan-analysis technology in research to identify cancer biomarkers.

April 23, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the election of Dennis A. Ausiello, M.D. to its Board of Directors and Scientific Advisory Board. Dr. Ausiello...

April 23, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (ISCO.OB), www.internationalstemcell.com, today announced that several of its senior...

April 23, 2012

CARLSBAD, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB: ISCO) (www.internationalstemcell.com) today announced it has appointed MZ...

April 23, 2012

KIRKLAND, Wash.--(BUSINESS WIRE)--ProteoTech's CSO to Present New Data at the XIIIth International Symposium on Amyloidosis in Netherlands, May 6-10, 2012

April 23, 2012

CHICAGO--(BUSINESS WIRE)--ClearTrial to present at Bio-IT World Conference & Expo on how life sciences companies are leveraging cloud-based systems to integrate and connect siloed functions to increase operational efficiency.

April 23, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--W. R. Grace & Co. (NYSE: GRA) and Formac Pharmaceuticals announce successful clinical trial demonstrating the novel use of silica for drug delivery.

April 23, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--IntegenX Inc. today announced that it has acquired an IP portfolio of DNA consumables from GE Healthcare Bio-Sciences for its rapid human identification system.

April 23, 2012

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the appointment of Gerald McMahon, Ph.D., as President and Chief Executive Officer. Dr. McMahon, who also has been nominated...

April 23, 2012

NEW YORK--(BUSINESS WIRE)--OrbiMed, a leading global investment management firm focused on the healthcare sector, is pleased to announce the closing of its first investment fund dedicated to life sciences venture capital opportunities based in...

April 23, 2012

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Meritas Health Corporation has chosen eClinicalWorks as its electronic medical records system. Meritas Health Corporation is a multi-specialty group in Kansas City, Mo., with 72 employed physicians.

April 23, 2012

MALVERN, Pa.--(BUSINESS WIRE)--John M. Gill, TetraLogic Pharmaceuticals’ President and Chief Executive Officer, received the prestigious annual Semper Fidelis Award which is presented each year to an outstanding American who has maintained...